Literature DB >> 11774284

Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration.

Teruo Iwasaki1, Atsushi Nakata, Mutsuko Mukai, Kiyoko Shinkai, Hajime Yano, Hisataka Sabe, Erik Schaefer, Masaharu Tatsuta, Tohru Tsujimura, Nobuyuki Terada, Eizo Kakishita, Hitoshi Akedo.   

Abstract

We demonstrated previously that rat ascites hepatoma MM1 cells require both lysophosphatidic acid (LPA) and fibronectin (FN) for phagokinetic motility and transcellular migration and that these events are regulated through the RhoA-ROCK pathway. It remains to be elucidated, however, how the signals from both LPA and FN are integrated into cell migration. To examine this, total cellular lysates after stimulation with LPA or FN were subjected to time-course immunoblot analysis with anti-phosphotyrosine antibodies (Abs). Consequently, tyrosine-phosphorylation of paxillin was obviously persistent after stimulation with FN + LPA as compared to after stimulation with either alone. Tyrosine-phosphorylated paxillin comprised 2 components; slowly and fast migrating ones. Immunoblotting of anti-paxillin immunoprecipitates with phosphorylation site-specific Abs revealed the following: tyrosine-phosphorylation was enhanced preferentially on a slowly migrating component after stimulation with FN + LPA; this component contained phosphorylation at both tyrosine residue (Y) 31 and Y118; and phosphorylation of paxillin at Y181 was constitutive and not augmented by stimulation with either FN or LPA. Amiloride, an inhibitor of the Na+/H+ antiporter downstream of ROCK, suppressed cell motility and correspondingly paxillin tyrosine-phosphorylation at both Y31 and Y118. Paxillin phosphorylation weakly induced by FN alone, insufficient for cell migration, was not inhibited by amiloride. These results demonstrate that LPA collaborates with FN for persistent tyrosine phosphorylation of paxillin at both Y31 and Y118, regulated by the Na+/H+ antiporter downstream of ROCK and that this phosphorylated paxillin is essential for MM1 cancer cell migration. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774284     DOI: 10.1002/ijc.1609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Dynamic motion of paxillin on actin filaments in living endothelial cells.

Authors:  Ying-Li Hu; Shu Chien
Journal:  Biochem Biophys Res Commun       Date:  2007-04-17       Impact factor: 3.575

2.  Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness.

Authors:  Michael C Brown; Leslie A Cary; Jennifer S Jamieson; Jonathan A Cooper; Christopher E Turner
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

3.  Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function.

Authors:  Panfeng Fu; Peter V Usatyuk; Jeffrey Jacobson; Anne E Cress; Joe G N Garcia; Ravi Salgia; Viswanathan Natarajan
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

4.  c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury.

Authors:  Panfeng Fu; Peter V Usatyuk; Abhishek Lele; Anantha Harijith; Carol C Gregorio; Joe G N Garcia; Ravi Salgia; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-20       Impact factor: 5.464

5.  KSHV-TK is a tyrosine kinase that disrupts focal adhesions and induces Rho-mediated cell contraction.

Authors:  Michael B Gill; Rachel Turner; Philip G Stevenson; Michael Way
Journal:  EMBO J       Date:  2014-12-03       Impact factor: 11.598

6.  Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.

Authors:  Anna A Birukova; Ivan Cokic; Nurgul Moldobaeva; Konstantin G Birukov
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-29       Impact factor: 6.914

7.  Outer membrane inflammatory protein A, a new virulence factor involved in the pathogenesis of Helicobacter pylori.

Authors:  Jinyong Zhang; Jiajun Qian; Xiaoli Zhang; Quanming Zou
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

8.  Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.

Authors:  Yutaka Hasegawa; Mandi Murph; Shuangxing Yu; Gabor Tigyi; Gordon B Mills
Journal:  Mol Oncol       Date:  2008-06       Impact factor: 6.603

9.  Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.

Authors:  Yan Liao; Ganggang Mu; Lingli Zhang; Wei Zhou; Jun Zhang; Honggang Yu
Journal:  Dig Dis Sci       Date:  2013-09-24       Impact factor: 3.199

10.  Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines.

Authors:  Rosa A Cardone; Anna Bagorda; Antonia Bellizzi; Giovanni Busco; Lorenzo Guerra; Angelo Paradiso; Valeria Casavola; Manuela Zaccolo; Stephan J Reshkin
Journal:  Mol Biol Cell       Date:  2005-04-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.